Precision Nanomedicine in Neurodegenerative Diseases-Reference-Cited by-同舟云学术

Precision Nanomedicine in Neurodegenerative Diseases

Published:2014-03-25 Issue:3 Volume:8 Page:1958-1965
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Goldsmith Meir¹,Abramovitz Lilach¹,Peer Dan¹

Affiliation:

1. Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Science, Department of Material Science and Engineering, and the Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 69978, Israel

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn501292z

Reference67 articles.

1. EPIDEMIOLOGY OF NEURODEGENERATION

2. Alzheimer's Disease

3. NEURODEGENERATIVE DISEASES: New Concepts of Pathogenesis and Their Therapeutic Implications

4. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier

5. Drug Transport across the Blood–Brain Barrier

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders;CNS & Neurological Disorders - Drug Targets;2024-10

2. Polymeric Nanoparticles for Drug Delivery;Chemical Reviews;2024-04-16

3. Physiological principles underlying the kidney targeting of renal nanomedicines;Nature Reviews Nephrology;2024-02-26

4. Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy;Advanced Materials;2024-02-08

5. Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine;Pharmaceutics;2024-02-07